RSCF (Reflect Scientific) Cash And Cash Equivalents: $1.68 Mil (As of Sep. 2025)


What is Reflect Scientific Cash And Cash Equivalents?

Reflect Scientific RSCF Cash And Cash Equivalents is $1.68 Mil as of Sep. 2025. The stock has 4 warning signs investors should review.

Reflect Scientific's quarterly cash and cash equivalents increased from Sep. 2024 ($1.03 Mil) to Jun. 2025 ($1.30 Mil) and increased from Jun. 2025 ($1.30 Mil) to Sep. 2025 ($1.68 Mil).

Reflect Scientific's annual cash and cash equivalents declined from Dec. 2021 ($1.47 Mil) to Dec. 2022 ($1.38 Mil) and declined from Dec. 2022 ($1.38 Mil) to Dec. 2023 ($1.28 Mil).

Reflect Scientific  (OTCPK:RSCF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Reflect Scientific Cash And Cash Equivalents Related Terms

Reflect Scientific Cash And Cash Equivalents Historical Data

* Premium members only.

The historical data trend for Reflect Scientific's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reflect Scientific Cash And Cash Equivalents Chart

Reflect Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.64 1.47 1.38 1.28

Reflect Scientific Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Jun25 Sep25
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 1.10 1.03 1.30 1.68

Reflect Scientific Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

What does a Cash And Cash Equivalents of $1.68 Mil mean?
Reflect Scientific (RSCF) has a Cash And Cash Equivalents of $1.68 Mil as of Sep. 2025. Cash and cash equivalents represents the total cash and other short-term investments on hand. View historical data on Reflect Scientific and its competitors.
Is Reflect Scientific's Cash And Cash Equivalents too high?
Reflect Scientific's current Cash And Cash Equivalents is $1.68 Mil.
How does Reflect Scientific's Cash And Cash Equivalents compare to GCTK and CBSC?
Reflect Scientific's Cash And Cash Equivalents of $1.68 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash And Cash Equivalents for a Medical Devices & Instruments company?
A good Cash And Cash Equivalents depends on the Medical Devices & Instruments industry context. However, Cash And Cash Equivalents should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash And Cash Equivalents mean?
A high Cash And Cash Equivalents can signal that a stock is expensive relative to its fundamentals. Cash and cash equivalents represents the total cash and other short-term investments on hand. View historical data on Reflect Scientific and its competitors. Reflect Scientific's current Cash And Cash Equivalents is $1.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Cash And Cash Equivalents of $1.68 Mil. The current Cash And Cash Equivalents is $1.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash And Cash Equivalents calculated?
Cash And Cash Equivalents is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Cash And Cash Equivalents is $1.68 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reflect Scientific Business Description

Address 1266 South 1380 West, Orem, UT, USA, 84058
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.